Alex Vitkin, Ph.D.

WASHINGTON, D.C. — The American Institute for Medical and Biological Engineering (AIMBE) has announced the election of Alex Vitkin, Ph.D., Professor, Medical Biophysics, University of Toronto to its College of Fellows. Dr. Vitkin was nominated, reviewed, and elected by peers and members of the AIMBE College of Fellows for outstanding contributions to optical imaging and diagnostic technologies for preclinical and clinical applications, and international outreach activities in biophotonics.

The College of Fellows is comprised of the top two percent of medical and biological engineers in the country. The most accomplished and distinguished engineering and medical school chairs, research directors, professors, innovators, and successful entrepreneurs comprise the College of Fellows. AIMBE Fellows are regularly recognized for their contributions in teaching, research, and innovation. AIMBE Fellows have been awarded the Nobel Prize, the Presidential Medal of Science and the Presidential Medal of Technology and Innovation, and many also are members of the National Academy of Engineering, National Academy of Medicine, and the National Academy of Sciences… Continue reading.

Alex Vitkin’s current positions as a professor of medical biophysics and radiation oncology at the University of Toronto, senior scientist in biophysics and bioimaging at the Ontario Cancer Institute, and radiation physicist at Toronto’s Princess Margaret Cancer Centre showcase his leading role in the field of biomedical engineering and medical physics in general, and in biophotonics in particular. A few of the highlights of his professional life include pioneering advanced high-SNR polarimetric system architectures using phase modulation and synchronous detection based on photo-elastic modulators; creating a computational modeling platform to properly account for various polarization effects of light propagation in complex turbid media such as biological tissues; building a robust, low-cost and objective polarization microscopy module for assessing tumor stroma in a digital pathology context; and innovating the coupling of polarimetric approaches with a complementary technology based on mass spectroscopy that enables a more powerful and accurate hybrid tool for breast-cancer assessment… Continue reading.